Table 5 Strength of the recommendations.
Recommendations | No of studies | Level of | Strength of | |
---|---|---|---|---|
evaluated | evidence | recommendation | ||
1 Early referral | 35 | Ib | B | |
2 Diagnosis of early synovitis | 30 | IIb | C | |
3 Minimum diagnostic procedure | _ | _ | D | |
4 Prediction of persistent and erosive arthritis | 45 | III | C | |
5 Early treatment start | 27 | Ia | A | |
6 Patient information | 26 | Ia/Ib | B | |
7 NSAIDs | 11 | Ia | B | |
8 Systemic and intra‐articular glucocorticoids | 21 | Ia | A | |
9 Methotrexate is the anchor drug | 24 | Ia | A | |
10 Treatment strategies | 22 | Ib | B | |
11 Non‐pharmaceutical interventions | 32 | Ia | B | |
12 Regular monitoring | 11 | Ia | A |
NSAID, non‐steroidal anti‐inflammatory drug.